ALL ALS is a proud contributor to the Accelerating Medicines Partnership® for ALS (AMP® ALS). AMP ALS is an essential component of the public-private partnership called for in Public Law 117-79 -Accelerating Access to Critical Therapies for ALS Act (ACT for ALS). AMP ALS is bringing together data and biospecimens from many different studies and facilitating broad use to improve diagnosis and develop effective therapies for ALS. This collaboration represents a significant step forward in ALS research, uniting government, industry, and non-profit organizations in the fight against this disease.